FDA Approved: PADCEV EJFV — Original Application (SEAGEN INC.)

View source ↗

Summary

The FDA approved PADCEV EJFV (enfortumab vedotin) from Seagen in its original application, marking the product's initial regulatory clearance. The approval is f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• PADCEV EJFV (enfortumab vedotin)

Snippet

ORIG AP for PADCEV EJFV (ENFORTUMAB VEDOTIN)